Clinical trial update: International Breast Cancer Study Group

by Price, Karen N, Goldhirsch, Aron
Published 2005

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

by Goldhirsch, Aron, Colleoni, Marco, Regan, Meredith
Published in Ecancermedicalscience (2015)

Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system

by Conforti, Fabio, Pala, Laura, Goldhirsch, Aron
Published in Oncotarget (2018)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

by Criscitiello, Carmen, Viale, Giulia, Curigliano, Giuseppe, Goldhirsch, Aron
Published in Breast Cancer (Dove Med Press) (2018)

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”

by Gelao, Lucia, Criscitiello, Carmen, Esposito, Angela, Goldhirsch, Aron, Curigliano, Giuseppe
Published 2014

The 6th Milan Breast Cancer Conference, Milan, Italy, 16–18 June 2004

by Gennari, Roberto, Cinieri, Saverio, Colleoni, Marco, Zurrida, Stefano, Goldhirsch, Aron, Veronesi, Umberto
Published 2005

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

by Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Published 2006

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

by Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Published 2006

International Web-based consultation on priorities for translational breast cancer research

by Dowsett, Mitch, Goldhirsch, Aron, Hayes, Daniel F, Senn, Hans-Joerg, Wood, William, Viale, Giuseppe
Published 2007

Best management of locally advanced inoperable breast cancer

by Curigliano, Giuseppe, Criscitiello, Carmen, Esposito, Angela, Fumagalli, Luca, Gelao, Lucia, Locatelli, Marzia, Minchella, Ida, Goldhirsch, Aron
Published 2013

Immune approaches to the treatment of breast cancer, around the corner?

by Criscitiello, Carmen, Esposito, Angela, Gelao, Lucia, Fumagalli, Luca, Locatelli, Marzia, Minchella, Ida, Adamoli, Laura, Goldhirsch, Aron, Curigliano, Giuseppe
Published 2014

Impact of autoimmune diseases on outcome of patients with early breast cancer

by Criscitiello, Carmen, Bagnardi, Vincenzo, Esposito, Angela, Gelao, Lucia, Santillo, Barbara, Viale, Giulia, Rotmensz, Nicole, Goldhirsch, Aron, Curigliano, Giuseppe
Published in Oncotarget (2016)

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

by Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco
Published 2006

Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer

by Sun, Zhuoxin, Goldhirsch, Aron, Price, Karen N., Colleoni, Marco, Ravaioli, Alberto, Simoncini, Edda, Campbell, Ian, Gelber, Richard D., Towler, Mark
Published 2009

Timing of radiotherapy and chemotherapy after breast-conserving surgery for node-positive breast cancer: long term results from IBCSG Trials VI and VII

by Karlsson, Per, Cole, Bernard F., Price, Karen N., Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron, Castiglione, Monica, Colleoni, Marco, Gruber, Günther
Published in Int J Radiat Oncol Biol Phys (2016)

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

by Mancuso, Patrizia, Colleoni, Marco, Calleri, Angelica, Orlando, Laura, Maisonneuve, Patrick, Pruneri, Giancarlo, Agliano, Alice, Goldhirsch, Aron, Shaked, Yuval, Kerbel, Robert S., Bertolini, Francesco
Published 2006

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

by Chirgwin, Jacquie, Sun, Zhuoxin, Smith, Ian, Price, Karen N., Thürlimann, Beat, Ejlertsen, Bent, Bonnefoi, Hervé, Regan, Meredith M., Goldhirsch, Aron, Coates, Alan S.
Published in Breast Cancer Res Treat (2011)

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy

by Karlsson, Per, Cole, Bernard F., Colleoni, Marco, Roncadin, Mario, Chua, Boon, Murray, Elizabeth, Price, Karen N., Castiglione-Gertsch, Monica, Goldhirsch, Aron, Gruber, Günther
Published 2010

Adjuvant!(©) Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breas...

by Paridaens, Robert J., Gelber, Shari, Cole, Bernard F., Gelber, Richard D., Thürlimann, Beat, Price, Karen N., Holmberg, Stig B., Crivellari, Diana, Coates, Alan S., Goldhirsch, Aron
Published 2010

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocri...

by Maiorano, Eugenio, Regan, Meredith M., Viale, Giuseppe, Mastropasqua, Mauro G., Colleoni, Marco, Castiglione-Gertsch, Monica, Price, Karen N., Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S.
Published 2009